alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

被引:51
|
作者
Eisbach, Sibylle E. [1 ]
Outeiro, Tiago F. [1 ]
机构
[1] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2013年 / 91卷 / 06期
关键词
alpha-Synuclein; Trafficking; Spreading; Prion; Transmission; Parkinson's disease; TO-NEURON TRANSMISSION; N-TERMINAL ACETYLATION; SUBSTANTIA-NIGRA; RAB GTPASES; SYNAPTIC DYSFUNCTION; AXONAL-TRANSPORT; IRON CONTENT; CELL-DEATH; IN-VITRO; MEMBRANE;
D O I
10.1007/s00109-013-1038-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein alpha-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of alpha-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that alpha-synuclein can be propagated between cells. Here, we discuss the molecular interplay of alpha-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 50 条
  • [41] The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease
    Sian-Hulsmann, Jeswinder
    Riederer, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (05) : 749 - 754
  • [42] Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
    Meade, Richard M.
    Fairlie, David P.
    Mason, Jody M.
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [43] Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more ...
    Rouaud, T.
    Corbille, A-G
    Leclair-Visonneau, L.
    de Lataillade, A. de Guilhem
    Lionnet, A.
    Preterre, C.
    Damier, P.
    Derkinderen, P.
    REVUE NEUROLOGIQUE, 2021, 177 (03) : 260 - 271
  • [44] Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease
    Allen, Scott G.
    Meade, Richard M.
    Stenner, Lucy L. White
    Mason, Jody M.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [45] Alpha-Synuclein Aggregation in Parkinson's Disease
    Srinivasan, E.
    Chandrasekhar, G.
    Chandrasekar, P.
    Anbarasu, K.
    Vickram, A. S.
    Karunakaran, Rohini
    Rajasekaran, R.
    Srikumar, P. S.
    FRONTIERS IN MEDICINE, 2021, 8
  • [46] Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
    Vekrellis, Kostas
    Stefanis, Leonidas
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) : 421 - 432
  • [47] LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease
    Alegre-Abarrategui, J.
    Ansorge, O.
    Esiri, M.
    Wade-Martins, R.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2008, 34 (03) : 272 - 283
  • [48] Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease
    Rouaud, Tiphaine
    Clairembault, Thomas
    Coron, Emmanuel
    Neunlist, Michel
    Anheim, Mathieu
    Derkinderen, Pascal
    PARKINSONISM & RELATED DISORDERS, 2017, 40 : 83 - 84
  • [49] Alpha-synuclein and Parkinson disease
    Hui Liu1
    Neural Regeneration Research, 2007, (04) : 239 - 243
  • [50] Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease
    He, Yixi
    Yu, Zhongwang
    Chen, Shengdi
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 777 - +